Loading...
Loading...
India's pembrolizumab imports from CHINA total $4.2K across 6 shipments from 3 foreign suppliers. GENSCRIPT BIOTECH SINGAPORE leads with $2.7K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include IMPERIAL LIFE SCIENCES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for pembrolizumab โ a concentrated sourcing relationship with select suppliers from CHINA.

GENSCRIPT BIOTECH SINGAPORE is the leading Pembrolizumab supplier from CHINA to India, with import value of $2.7K across 2 shipments. The top 5 suppliers โ GENSCRIPT BIOTECH SINGAPORE, LIFE TECHNOLOGIES LIMITED, BIO-RAD ABD SEROTEC LIMITED โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GENSCRIPT BIOTECH SINGAPORE | $2.7K | 2 | 63.2% |
| 2 |
| LIFE TECHNOLOGIES LIMITED |
| $826 |
| 3 |
| 19.6% |
| 3 | BIO-RAD ABD SEROTEC LIMITED | $721 | 1 | 17.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | IMPERIAL LIFE SCIENCES PRIVATE LIMITED | $2.7K | 2 | 63.2% |
| 2 | BIO RAD LABORATORIES I PRIVATE LIMITED | $721 | 1 | 17.2% |
| 3 | INTAS PHARMACEUTICALS LIMITED | $611 | 2 | 14.5% |
| 4 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | $214 | 1 | 5.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Pembrolizumab suppliers from CHINA to India include GENSCRIPT BIOTECH SINGAPORE, LIFE TECHNOLOGIES LIMITED, BIO-RAD ABD SEROTEC LIMITED. The leading supplier is GENSCRIPT BIOTECH SINGAPORE with import value of $2.7K USD across 2 shipments. India imported Pembrolizumab worth $4.2K USD from CHINA in total across 6 shipments.
India imported Pembrolizumab worth $4.2K USD from CHINA across 6 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Pembrolizumab sourced from CHINA include IMPERIAL LIFE SCIENCES PRIVATE LIMITED, BIO RAD LABORATORIES I PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED. The largest buyer is IMPERIAL LIFE SCIENCES PRIVATE LIMITED with $2.7K in imports across 2 shipments.
The total value of Pembrolizumab imports from CHINA to India is $4.2K USD, across 6 shipments and 3 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6 Verified Shipments
3 suppliers, 4 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists